Browsing: Pharma

Typically, at major pharmaceutical companies’ earnings conferences, executives talk enthusiastically about new products and tout…

And there was nothing. Regeneron’s announcement of a drug pricing agreement with the White House…

Travis Smith was a very serious baby. His mother, Sierra, who was born completely deaf,…

The magnitude of the currency headwinds in Roche’s first-quarter earnings report caught many off guard,…

In a difficult first quarter for Roche, the company’s pharmaceuticals division’s core drugs fared well…

The FDA’s new approach to releasing redacted Complete Response Letters (CRLs) in the name of…

The recent launch of Novo Nordisk’s Wegoby pill has opened up the oral GLP-1 market…

Almost two-thirds of Americans use artificial intelligence-based tools to seek medical information, but about one-third…

Explore 2026 pharma trends in drug discovery, biopharma manufacturing, clinical pipelines, and FDA approvals to overcome bottlenecks and drive success for pharmacologists, executives, and regulatory professionals.

Merck’s $1 billion deal with Google Cloud aims to boost its AI credentials, and the…